Heterogeneous functional effects of concomitant B cell receptor and TLR stimulation in chronic lymphocytic leukemia with mutated versus unmutated Ig genes
- PMID: 24719462
- DOI: 10.4049/jimmunol.1302102
Heterogeneous functional effects of concomitant B cell receptor and TLR stimulation in chronic lymphocytic leukemia with mutated versus unmutated Ig genes
Abstract
We recently reported that chronic lymphocytic leukemia (CLL) subgroups with distinct clonotypic BCRs present discrete patterns of TLR expression, function, and/or tolerance. In this study, to explore whether specific types of BCR/TLR collaboration exist in CLL, we studied the effect of single versus concomitant BCR and/or TLR stimulation on CLL cells from mutated (M-CLL) and unmutated CLL (U-CLL) cases. We stimulated negatively isolated CLL cells by using anti-IgM, imiquimod, and CpG oligodeoxynucleotide for BCR, TLR7, and TLR9, respectively, alone or in combination for different time points. After in vitro culture in the absence of stimulation, differences in p-ERK were identified at any time point, with higher p-ERK levels in U-CLL versus M-CLL. Pronounced p-ERK induction was seen by single stimulation in U-CLL, whereas BCR/TLR synergism was required in M-CLL, in which the effect was overall limited in scale. An opposite pattern was observed regarding induction of apoptosis, as studied by Western blotting for the cleaved fragment of poly(ADP-ribose) polymerase, and the active isoform of caspase-8, with M-CLL responding even to single stimulation, contrasting with U-CLL that showed minimal response. Our findings suggest that concomitant engagement of BCR and TLR leads to differential responses in CLL depending on the mutational status of the BCR. Differential intensity and duration of responses in M-CLL versus U-CLL indicates that the differences in signal transduction between the two subgroups may be primarily quantitative rather than qualitative.
Similar articles
-
TLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B Cells.J Immunol. 2015 Aug 1;195(3):901-23. doi: 10.4049/jimmunol.1403189. Epub 2015 Jul 1. J Immunol. 2015. PMID: 26136429 Free PMC article.
-
B cell TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: modulation by BCR and CD40, and relevance to T-independent antibody responses.Autoimmunity. 2015 Feb;48(1):1-12. doi: 10.3109/08916934.2014.993027. Autoimmunity. 2015. PMID: 25536171 Free PMC article.
-
Distinct innate immunity pathways to activation and tolerance in subgroups of chronic lymphocytic leukemia with distinct immunoglobulin receptors.Mol Med. 2012 Dec 6;18(1):1281-91. doi: 10.2119/molmed.2011.00480. Mol Med. 2012. PMID: 22437326 Free PMC article.
-
Antigen stimulation in the development of chronic lymphocytic leukemia.Postepy Hig Med Dosw (Online). 2013 Dec 5;67:1204-13. doi: 10.5604/17322693.1078852. Postepy Hig Med Dosw (Online). 2013. PMID: 24379261 Review.
-
Stereotyped B-cell receptors in chronic lymphocytic leukemia.Leuk Lymphoma. 2014 Oct;55(10):2252-61. doi: 10.3109/10428194.2013.879715. Epub 2014 Mar 17. Leuk Lymphoma. 2014. PMID: 24397617 Review.
Cited by
-
Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8.Blood. 2015 Jun 4;125(23):3580-7. doi: 10.1182/blood-2014-09-603217. Epub 2015 Apr 21. Blood. 2015. PMID: 25900981 Free PMC article. Clinical Trial.
-
B Cell Receptor Immunogenetics in B Cell Lymphomas: Immunoglobulin Genes as Key to Ontogeny and Clinical Decision Making.Front Oncol. 2020 Jan 31;10:67. doi: 10.3389/fonc.2020.00067. eCollection 2020. Front Oncol. 2020. PMID: 32083012 Free PMC article. Review.
-
In-vitro Modulation of mTOR-HIF-1α Axis by TLR7/8 Agonist (Resiquimod) in B-Chronic Lymphocytic Leukemia.Indian J Hematol Blood Transfus. 2023 Oct;39(4):537-545. doi: 10.1007/s12288-023-01649-y. Epub 2023 Apr 7. Indian J Hematol Blood Transfus. 2023. PMID: 37786827 Free PMC article.
-
Heterogeneity of Toll-like receptor 9 signaling in B cell malignancies and its potential therapeutic application.J Transl Med. 2017 Feb 27;15(1):51. doi: 10.1186/s12967-017-1152-5. J Transl Med. 2017. PMID: 28241765 Free PMC article. Review.
-
TLR Signaling Is Activated in Lymph Node-Resident CLL Cells and Is Only Partially Inhibited by Ibrutinib.Cancer Res. 2019 Jan 15;79(2):360-371. doi: 10.1158/0008-5472.CAN-18-0781. Epub 2018 Nov 29. Cancer Res. 2019. PMID: 30498085 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous